The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This post provides an overview of how health care coverage and access will and won’t change when the public health emergency ends on May 11, including a discussion of COVID-19 vaccines, tests, and treatments, and telemedicine.
This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.
This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.
With an impasse in Congress over additional COVID-19 emergency funding, uninsured people could lose access to free testing and treatment services, a new KFF brief explains. For people without health insurance, the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program has reimbursed hospitals, doctors and other providers for the COVID-19 care and services that they provide to uninsured people. However, with federal funds running out, the program is no longer accepting new claims for…
January 27, 2022 – OB-GYNs, a nurse and midwife affirm the safety of the COVID-19 vaccine during pregnancy and debunk myths about the impact on fertility in 40+ new FAQ videos from THE CONVERSATION / LA CONVERSACIÓN. This installment of the campaign is produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response and is funded by the California Health Care Foundation. According to the Centers for Disease Control and Prevention…
Misinformation and confusion about the COVID-19 vaccines and pregnancy remains widespread, with most people – including women who are pregnant or trying to get pregnant – either believing or being uncertain about at least one of three false claims they’ve heard, a new KFF COVID-19 Vaccine Monitor shows. Among women who are pregnant or trying to get pregnant – the group for whom accurate information about the vaccines’ safety before, during and after pregnancy is…
COVID-19 vaccine uptake among adolescents ages 12-17 has slowed after an initial wave of enthusiasm over the summer, with half (49%) of parents saying their adolescent has received at least one dose, a new KFF COVID-19 Vaccine Monitor report reveals. The share is little changed since earlier in the fall. Just 1% of parents of adolescents now say they will get their adolescent vaccinated as soon as possible, and 13% say they want to wait…
Just 7% of low-income countries' populations have received at least one dose of a COVID-19 vaccine as of December 20, well behind the 40% target for 2021.
This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence misinformation and AI's role in spreading false mental health information.
New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards…
© 2026 KFF